共 131 条
[1]
Elixhauser A., Luce B.R., Taylor W.R., Reblando J., Health care CBA/CEA: An update on the growth and composition of the literature, Med Care, 31, 7 SUPPL., (1993)
[2]
Elixhauser A., Halpern M., Schmier J., Luce B.R., Health care CBA and CEA from 1991 to 1996: An updated bibliography, Med Care, 36, 5 SUPPL., (1998)
[3]
Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., Gardiner J., Cost-effectiveness analysis in heart disease, Part II: Preventive therapies, Prog Cardiovasc Dis, 37, 4, pp. 243-271, (1995)
[4]
Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., Gardiner J., Cost-effectiveness analysis in heart disease, Part I: General principles, Prog Cardiovasc Dis, 37, 3, pp. 161-184, (1994)
[5]
Kupersmith J., Holmes-Rovner M., Hogan A., Rovner D., Gardiner J., Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias, Prog Cardiovasc Dis, 37, 5, pp. 307-346, (1995)
[6]
Guide to the Methods of Technology Appraisal, (2004)
[7]
Fagan T., Sunthareswaren R., Crash Course: Cardiovascular System, 2nd Edition, (2002)
[8]
Torrance G.W., Feeny D., Utilities and quality-adjusted life years, Int J Technol Assess Health Care, 5, 4, pp. 559-575, (1989)
[9]
Evans C., Tavakoli M., Crawford B., Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: A critical appraisal, Health Care Manag Sci, 7, 1, pp. 43-49, (2004)
[10]
Russell L.B., Gold M.R., Siegel J.E., Daniels N., Weinstein M.C., The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine, JAMA, 276, 14, pp. 1172-1177, (1996)